Form 4 for RGNX REGENXBIO Inc.
Accepted 2026-06-02 17:20:47 ET · period of report 2026-05-29 · accession 0001737231-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-02 17:20 | 2026-05-29 | RGNX | Zachary Jennifer | Dir | A - Grant | $0.00 | +9,807 | 31.9K | +44% | $0 |
| D | 2026-06-02 17:20 | 2026-05-29 | RGNX | Zachary Jennifer | Dir | A - Grant | $0.00 | +46.6K | 46.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-29 | A | A | 9,807 | $0.00 | 31,871 | D | — | — | (F1) Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer. |
| 2 | Derivative | Stock Options (Right to Buy) | 2026-05-29 | A | A | 46,600 | $0.00 | 46,600 | D | $7.01 · 2027-05-29 to 2036-05-29 | 46,600 Common Stock | (F2) The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer. |